Literature DB >> 25691720

Industry perspective on the medical risk of visible particles in injectable drug products.

Stan Bukofzer, John Ayres, Anna Chavez, Minerva Devera, Jahanvi Miller, Douglas Ross, John Shabushnig, Susan Vargo, Harry Watson, Rick Watson.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25691720     DOI： 10.5731/pdajpst.2015.01037

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN： 1079-7440


× No keyword cloud information.
  4 in total

1.  Effect of Technically Relevant X-Ray Doses on the Structure and Function of Alcohol Dehydrogenase and Hen Egg-White Lysozyme.

Authors:  Lisa-Marie Schaden; Miriam Wimmer-Teubenbacher; Johannes Poms; Peter Laggner; Karl Lohner; Stephan Sacher; Johannes G Khinast; Sharareh Salar-Behzadi
Journal:  Pharm Res       Date:  2018-05-07       Impact factor: 4.200

2.  Method to Determine Syringe Silicone Oil Layer Heterogeneity and Investigation of its Impact on Product Particle Counts.

Authors:  Michelle Cua; Daniel Martin; Patricia Meza; Gianni Torraca; Thomas Pearson; Shawn Cao; Changhuei Yang
Journal:  J Pharm Sci       Date:  2020-07-15       Impact factor: 3.534

3.  Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.

Authors:  Jeff Sedita; Stefanie Perrella; Matt Morio; Michael Berbari; Jui-Shan Hsu; Eugene Saxon; Courtney Jarrahian; Annie Rein-Weston; Darin Zehrung
Journal:  Vaccine       Date:  2018-02-12       Impact factor: 3.641

4.  Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics.

Authors:  Marisa K Joubert; Meghana Deshpande; Jane Yang; Helen Reynolds; Christine Bryson; Mark Fogg; Matthew P Baker; Jonathan Herskovitz; Theresa J Goletz; Lei Zhou; Michael Moxness; Gregory C Flynn; Linda O Narhi; Vibha Jawa
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.